Maxepa

Known as: Max EPA 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2018
0102019832018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
BACKGROUND & AIMS n-3 polyunsaturated fatty acids reduce insulin resistance, lipogenesis, and inflammation, which are features of… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2009
2009
Eicosapentaenoic acid (EPA) is a member of the family of n-3 polyunsaturated fatty acids (PUFAs) that are clinically used to… (More)
Is this relevant?
2003
2003
BACKGROUND n-3 Polyunsaturated fatty acids (PUFAs) have been suggested as a treatment for ulcerative colitis (UC). However, the… (More)
Is this relevant?
2000
2000
We investigated the effect of long-term administration of highly purified eicosapentaenoic acid ethyl ester (EPA-E), an n-3… (More)
Is this relevant?
1999
1999
We investigated the effect of long-term administration of highly purified eicosapentaenoic acid ethyl ester (EPA-E), an n-3… (More)
Is this relevant?
1997
1997
BACKGROUND Marine fish oils improve vascular function, but the mechanism of benefit is unclear. We conducted a study to examine… (More)
Is this relevant?
1995
1995
Dietary cod-liver oil containing eicosapentaenoic acid is effective on microvascular albumin leakage in diabetic patients with… (More)
Is this relevant?
1990
1990
Seventeen patients with moderately active SLE participated in a double-blind, crossover study on the effect of MaxEPA, using… (More)
Is this relevant?
1989
1989
Adult male, chow-fed Sprague-Dawley rats were given intraduodenally a bolus of emulsion of 0.5 ml of fish oil (MaxEPA) or olive… (More)
Is this relevant?
1989
1989
The effect of dietary supplementation with 20 capsules/day Maxepa or olive oil on serum lipids has been studied in 21… (More)
Is this relevant?